Clinical Focus

  • Psychiatry

Academic Appointments

  • Clinical Assistant Professor, Psychiatry and Behavioral Sciences

Professional Education

  • Residency:Stanford Hospital and Clinics (2008) CA
  • Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2011)
  • Residency:UCSF Medical Center (2001) CA
  • Medical Education:University of California San Francisco (1998) CA
  • Residency, Stanford University, Psychiatry (2008)
  • Residency, U.C. San Francisco, Internal Medicine (2001)
  • M.D., U.C. San Francisco, Medicine (1998)
  • M.S., U.C. Berkeley Joint Program, Health and Medical Sciences (1996)

Research & Scholarship

Current Research and Scholarly Interests

Pharmacological Treatments and Functional Imaging (fMRI) in Obsessive Compulsive Disorder, Trichotillomania, and Impulse Control Disorders

Clinical Trials

  • Trial of Aripiprazole in Trichotillomania Not Recruiting

    No medication has been reliably shown to benefit those suffering from trichotillomania (compulsive hair pulling). The current study proposes to evaluate the effectiveness of the medication aripiprazole for treatment of trichotillomania (TTM). Patients will take a gradually increased dose of the medication in an open-label study to see whether it relieves hair-pulling urges, decreases hair pulling behavior and is well tolerated.

    Stanford is currently not accepting patients for this trial. For more information, please contact Matthew White, (650) 725 - 5598.

    View full details

  • Functional Magnetic Resonance Imaging (MRI) of Hypnosis and Mindfulness Meditation Not Recruiting

    Hypnotic trance and mindfulness meditation have both been shown to have benefits for physical health. The current study seeks to determine if there are distinct patterns of brain activity that correlate with hypnotic trance, mindfulness meditation or both, and to relate these patterns to measurable markers of physical well-being. Precise neuroimaging of heightened attentional states will guide future researchers and practitioners toward more effective techniques of mind/body control.

    Stanford is currently not accepting patients for this trial. For more information, please contact Matthew P White, MD, 650-725-5598.

    View full details


All Publications

  • Open-Label Trial of Aripiprazole in the Treatment of Trichotillomania JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY White, M. P., Koran, L. M. 2011; 31 (4): 503-506


    Serotonin reuptake inhibitors have been disappointing in the treatment of trichotillomania (TTM). Recent evidence suggests that medications that modulate dopamine may be helpful in this disorder.To determine if the D2 partial agonist aripiprazole would be effective in the treatment of TTM.Twelve subjects participated in an 8-week, open-label, flexible-dose study of aripiprazole treatment of TTM. Primary end points were reduction in the Massachusetts General Hospital Hair Pulling Scale (MGHHPS) and MGHHPS Actual Pulling Subscale (MGHHPS-APS). Secondary end points were the Clinical Global Impressions-Improvement Scale, Hamilton Anxiety Scale, Hamilton Depression Scale, Beck Depression Inventory, and Beck Anxiety Inventory.Eleven of 12 subjects had 2 or more assessments; one subject dropped out during the first week. For subjects with 2 or more assessments, there was a significant mean reduction in both primary end points, the MGHHPS score (mean change, 7.8; SD, ± 7.8; P ? 0.01) and the MGHHPS-APS score (mean change, 3.9; SD, ± 4.1; P ? 0.02). Seven subjects had a greater than 50% reduction in MGHHPS; 7 subjects had an exit Clinical Global Impressions-Improvement Scale of 2 or lower, and 5 participants had absolute exit scores of 3 or lower on the MGHHPS and 1 or lower on the MGHHPS-APS. There were no significant changes in mood-related secondary end points. The mean aripiprazole dose for all completers (N = 11) was 7.5 mg/d (± 3.4 mg/d).This small open-label study suggests that aripiprazole is a promising treatment for the treatment of trichotillomania. Larger double-blind, placebo-controlled studies are needed to follow up on these findings.

    View details for DOI 10.1097/JCP.0b013e318221b1ba

    View details for Web of Science ID 000292284600015

    View details for PubMedID 21694623

  • Hypnosis, Mindfulness Meditation, and Brain Imaging, Book Chapter in Hypnosis and Hypnotherapy. Hypnosis and Hypnotherapy. Spiegel D, White MP 2010
  • Medication Dosing in Anxiety Disorders: What the Evidence Shows, Primary Psychiatry White MP 2009; 16 (10): 21-28